8:00 am Check-In & Coffee
09:00 AM – 12:00 AM | Workshop A
Evaluating Preclinical Models to Select the Most Applicable for Your Pipeline to Streamline Translation to the Clinic
Synopsis
Finding models for neurological disorders is challenging, especially for complex indications such as Alzheimer’s, Parkinson’s, MS, ALS and more. This session aims to explore a wide range of indications and showcase the most innovative models to represent diseases with physical, genetic or sporadic origin.
Join this session to:
- Breakdown the challenges involved in modelling neurological disorders such as trying to model a disease with sporadic origin
- Showcase how humanized mouse/non-human primate models can be used to model neurological disorders
- Consider the advantages and disadvantages for the current models, and discuss the innovations needed for more ideal models in the future
12:00 pm Lunch Break & Networking
1:00 PM – 04:00 PM | Workshop B
Understanding Investor Perspectives to Secure Partnerships & Push Forward the Potential of Cell Therapies for Neurological Disorders
Synopsis
Gaining partnerships with pharmaceutical companies and securing funding from investors is paramount to small biotech companies to accelerate their pipelines. Therefore, it is important to understand how to distinguish your company to maximize these opportunities.
Join this session to:
- Delve into what investors are looking for in small biotech with cell therapy pipelines for neurological disorders, and set goals to meet the necessary criteria
- Drive collaboration opportunities by learning what large pharmaceutical companies desire in partnerships
- Review the scope for investment and partnerships in this space to plan for the future